Impact of the affordability of novel agents in patients with multiple myeloma: Real ‐world data of current clinical practice in Mexico

CONCLUSIONSStage at diagnosis, induction regimen, and autologous stem cell transplantation were found to be contributors to survival disparities between patients with MM treated at PubC compared with PrivC in Mexico. These findings underscore the need to improve access to novel agents and stem cell transplantation in public health systems. Cancer 2018. © 2018 American Cancer Society.

Source: Cancer - February 15, 2018 Category: Cancer & Oncology Authors: Luz Tar ín‐Arzaga, Daniela Arredondo‐Campos, Victor Martínez‐Pacheco, Odra Martínez‐González, Alba Ramírez‐López, Adrés Gómez‐De León, Cesar Homero Gutiérrez‐Aguirre, Olga Cantú‐Rodríguez, José Carlos Jaime‐Pérez, David Gó Tags: Original Article Source Type: research